Bellevue Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-78
| Closed | -$1K | – | 517 |
|
2022
Q1 | $1K | Sell |
78
-14
| -15% | -$179 | ﹤0.01% | 514 |
|
2021
Q4 | $2K | Sell |
92
-7
| -7% | -$152 | ﹤0.01% | 498 |
|
2021
Q3 | $2K | Hold |
99
| – | – | ﹤0.01% | 522 |
|
2021
Q2 | $3K | Sell |
99
-9
| -8% | -$273 | ﹤0.01% | 454 |
|
2021
Q1 | $3K | Sell |
108
-16
| -13% | -$444 | ﹤0.01% | 515 |
|
2020
Q4 | $6K | Sell |
124
-41
| -25% | -$1.98K | ﹤0.01% | 392 |
|
2020
Q3 | $5K | Buy |
165
+38
| +30% | +$1.15K | ﹤0.01% | 388 |
|
2020
Q2 | $3K | Hold |
127
| – | – | ﹤0.01% | 479 |
|
2020
Q1 | $5K | Buy |
127
+52
| +69% | +$2.05K | 0.01% | 387 |
|
2019
Q4 | $2K | Buy |
+75
| New | +$2K | ﹤0.01% | 438 |
|